Eastman Chemical (EMN) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.84
- Estimate
- $1.92
- Surprise
- -4.0%
- Revenue (period 2026-09-30)
- $2.38B
- Score at report (before → after)
- 5.9 → 5.8/10
Revenue source: xbrl.
How the report landed
Eastman Chemical (EMN) missed the $1.92 estimate with adjusted EPS of $1.84 — a clear 4.0% shortfall. TrendMatrix's engine moved from Buy (Wait) (5.9/10) to Sell at 5.8/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates EMN Sell at 5.8/10.
3 of the last 4 quarters beat the estimate; this quarter's -4.0% surprise compares with a +2.7% four-quarter average. Next scheduled report: 2027-01-28.
What supports the rating
- Strong earnings beat streak (3/4)
- Attractive valuation
What argues against it
- Thin upside margin: 9.6%
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1)
- Sector modifier (Basic Materials): -0.1
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $61.71
- Price target
- $67.61
- Stop
- $59.18
- Upside to target
- +9.6%
- Reward-to-risk
- 1.6:1
At 11.1× trailing and 9.6× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-11-19 — shown for context, not personalized investment advice.
EMN at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $7.13B
- P/E (fwd)
- 9.6
- P/E (ttm)
- 11.1
- 52-week range
- $56.11–$83.47
- Off 52-week high
- 26.1%
- RSI (14)
- 33
- Volume vs avg
- 0.90×
- Score today
- 5.8/10